Anthony Margherita, MD
Physical Medicine & Rehabilitation · St Louis, MONPI 1750323028
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,788 of the $3,501 with a category attached, or 79.6%. It is spread thinly across 40 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,262 and has fallen 63.0% since, to $467 in 2025.
Across 112 payments — averaging $31.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$758
- Lilly USA, LLC$465
- AbbVie$180
- Collegium Pharmaceutical, Inc.$158
- Arbor Pharmaceuticals, Inc.$155
- Nevro Corp.$150
- plus $2K from 34 others
What the payments were for
- Food & beverage$2,78880%
- Education$71320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 3 | $758 |
| Lilly USA, LLC | 20 | $465 |
| AbbVie | 3 | $180 |
| Collegium Pharmaceutical, Inc. | 12 | $158 |
| Arbor Pharmaceuticals, Inc. | 11 | $155 |
| Nevro Corp. | 1 | $150 |
| Johnson & Johnson(2 entities) | 2 | $132 |
| Si-bone, Inc. | 1 | $129 |
| Vertos Medical, Inc. | 1 | $124 |
| GSK | 1 | $122 |
| Pacira Therapeutics, Inc. | 5 | $120 |
| International Rehabilitative Sciences, Inc | 1 | $115 |
| Medtronic | 4 | $90 |
| Amgen(2 entities) | 5 | $90 |
| Merck | 4 | $68 |
| Scilex Pharmaceuticals Inc. | 3 | $57 |
| Sobi, Inc | 2 | $52 |
| Assertio Therapeutics, Inc. | 3 | $45 |
| Pfizer | 3 | $40 |
| AstraZeneca | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Edwards Lifesciences | 1 | $29 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
| MDD US Operations, LLC | 2 | $26 |
| Lundbeck LLC | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Sanofi | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Protega Pharmaceutials Inc | 1 | $18 |
| Tonix Medicines, Inc. | 1 | $18 |
| Virtus Pharmaceuticals LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| UCB, Inc. | 1 | $16 |
| Abbott | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| BETA Bionics, Inc. | 1 | $14 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$150
- iFuse Implant$129
- mild Device Kit$124
- QULIPTA$123
- UBRELVY$123
- AREXVY$122
- MOUNJARO$121
- RS 4i Plus Sequential Stimulator$115
- SPRAVATO$100
How this compares
$3,501 in reported general payments places this provider in the 85th percentile of 182 physical medicine & rehabilitation providers in Missouri.
See all physical medicine & rehabilitation providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $9,684 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 172 | $4,785 |
| Fentanyl | 29 | $3,328 |
| Oxycodone Hcl | 64 | $1,755 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $1,181 |
| Methadone Hcl | 33 | $1,068 |
| Tramadol Hcl | 122 | $722 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $553 |
| Prednisone | 165 | $536 |
| Gabapentin | 47 | $412 |
| Baclofen | 19 | $119 |
| Meloxicam | 13 | $64 |
| Alprazolam | 18 | $53 |
| Lorazepam | 19 | $50 |
| Clonidine Hcl | 17 | $9 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in St Louis
- Lizette AlvarezSaint Louis$182K
- Heidi HunterCape Girardeau$150K
- Constantine FotopoulosKansas City$91K
- Joseph BurrisColumbia$75K
- Alexander ChamessianCreve Coeur$55K
- Jane EmersonColumbia$44K
- Reza FaridColumbia$37K
- Nathan KenyonJefferson City$24K
- Kunj PatelSaint Louis$17K
- Vovanti JonesColumbia$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.